%0 Journal Article %A Jacqueline A. Carozza %A Volker Böhnert %A Kelsey E. Shaw %A Khanh C. Nguyen %A Gemini Skariah %A Jenifer A. Brown %A Marjan Rafat %A Rie von Eyben %A Edward E. Graves %A Jeffrey S. Glenn %A Mark Smith %A Lingyin Li %T 2’3’-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1 %D 2019 %R 10.1101/539312 %J bioRxiv %P 539312 %X 2’3’-cyclic GMP-AMP (cGAMP) is characterized as an intracellular second messenger that is synthesized in response to cytosolic dsDNA and activates the innate immune STING pathway. Our previous discovery of its extracellular hydrolase ENPP1 hinted at the existence of extracellular cGAMP. Here, using mass spectrometry, we detected that cGAMP is continuously exported as a soluble factor by an engineered cell line but then efficiently cleared by ENPP1, explaining why it has escaped detection until now. By developing a potent, specific, and cell impermeable ENPP1 inhibitor, we detected cGAMP export in cancer cell lines commonly used for mouse tumor models. In tumors, depletion of extracellular cGAMP using neutralizing proteins decreased tumor-associated dendritic cells. Boosting extracellular cGAMP by genetic knockout and pharmacological inhibition of ENPP1 increased tumor-associated dendritic cells, shrunk tumors, and synergized with ionizing radiation and anti-CTLA-4 to cure tumors. In conclusion, cGAMP is an anti-cancer immunotransmitter released by tumors and detected by host innate immunity. %U https://www.biorxiv.org/content/biorxiv/early/2019/02/03/539312.full.pdf